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Desulfation of Heparan Sulfate 
by Sulf1 and Sulf2 Is Required for 
Corticospinal Tract Formation
Takuya Okada1, Kazuko Keino-Masu1, Satoshi Nagamine1,6, Fuyuki Kametani  4, Tatsuyuki 
Ohto1,2, Masato Hasegawa4, Toin H. van Kuppevelt5, Satoshi Kunita3,7, Satoru Takahashi3 & 
Masayuki Masu1
Heparan sulfate (HS) has been implicated in a wide range of cell signaling. Here we report a novel 
mechanism in which extracellular removal of 6-O-sulfate groups from HS by the endosulfatases, Sulf1 
and Sulf2, is essential for axon guidance during development. In Sulf1/2 double knockout (DKO) mice, 
the corticospinal tract (CST) was dorsally displaced on the midbrain surface. In utero electroporation 
of Sulf1/2 into radial glial cells along the third ventricle, where Sulf1/2 mRNAs are normally expressed, 
rescued the CST defects in the DKO mice. Proteomic analysis and functional testing identified Slit2 as 
the key molecule associated with the DKO phenotype. In the DKO brain, 6-O-sulfated HS was increased, 
leading to abnormal accumulation of Slit2 protein on the pial surface of the cerebral peduncle and 
hypothalamus, which caused dorsal repulsion of CST axons. Our findings indicate that postbiosynthetic 
desulfation of HS by Sulfs controls CST axon guidance through fine-tuning of Slit2 presentation.
Heparan sulfate (HS) is a polysaccharide attached to the core poteins of proteoglycans present in the extracellu-
lar matrix (ECM) and on the cell surface1–4. It interacts with growth factors, morphogens, and their receptors, 
thereby regulating their distribution and signal transduction. HS consists of repeating disaccharides, each of 
which is composed of hexuronic acid (glucuronic acid or iduronic acid) and N-acetylglucosamine. During bio-
synthesis, its sugar backbone undergoes extensive sulfation at some of the 2-O-positions of iduronic acids and 
the 3-O-, 6-O-, and N-positions of glucosamine residues. Because sulfation patterns of the sugar chain determine 
whether HS binds to ligands and how strong the binding is, biochemical studies of HS sulfation by sulfotrans-
ferases during biosynthesis have been the central issue in understanding the functional roles of HS.
This classical view was revised by the discovery of the endosulfatases, Sulfatase 1 (Sulf1) and Sulfatase 2 
(Sulf2), which selectively remove 6-O-sulfate groups from mature HS in the extracellular space after HS biosyn-
thesis is completed5,6. They preferentially act on trisulfated disaccharides possessing sulfate groups at the 2-O-, 
6-O-, and N-positions in HS. Through 6-O-desulfation, Sulfs regulate multiple signaling pathways positively or 
negatively5,6. Their physiological roles have been uncovered by analyzing Sulf knockout (KO) mice: single KO 
mice appear largely normal, whereas double knockout (DKO) mice show multiple defects in growth, develop-
ment, and regeneration7–13. However, the roles of Sulfs in neural circuit formation in vivo have yet to be elucidated.
In this study, we report that Sulf1/2 DKO mice have axon guidance defects in the corticospinal tract (CST). 
We provide evidence that abnormal accumulation of Slit2 protein, caused by increases in 6-O-sulfated HS, leads 
to axonal defects. Our findings demonstrate that Sulf-mediated HS desulfation in the ECM controls CST axon 
guidance through regulating the appropriate Slit2 presentation.
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Results
Sulf1 and Sulf2 Play a Role in Generating Sulfation Patterns of HS In Vivo. To assess whether 
the sulfation patterns of HS are changed in Sulf KO brains, we first performed HS disaccharide analysis. Because 
Sulf1/2 DKO mice died within a day of birth for unknown reasons, we used neonatal mice. HS was digested into 
disaccharides by heparin lyases, and the compositions of 8 different disaccharides possessing sulfate residues 
at different combinations at the 2-O-, 6-O-, and N-positions were determined by HPLC analysis. The Sulf1 KO 
and Sulf2 KO brains showed increases in 2-O-, 6-O-, and N-sulfated disaccharides and decreases in 2-O- and 
N-sulfated disaccharides (Supplementary Fig. S1a–b). In the Sulf1/2 DKO brains, the changes were more than a 
simple additive effect of the two single mutants (Supplementary Fig. S1a–b), indicating redundant roles of Sulf1 
and Sulf2. The sulfation profiles of chondroitin sulfate were not changed in the mutant brains (data not shown). 
These results demonstrate that Sulf1 and Sulf2 play a cooperative role in generating the sulfation patterns of HS 
in neonatal brains.
Sulf1/2 DKO Mice Have Defects in CST Axon Guidance. Because no gross brain malformations were 
observed, we performed intensive histological searches for possible abnormalities in the nerve tracts of Sulf1/2 
DKO mice. Consequently, we found that the cerebral peduncle was aberrant and the pyramidal tract was reduced 
in size in neurofilament-M-stained brain sections (Supplementary Fig. S1n–o), indicating that the Sulf1/2 DKO 
mice had defects in the CST. The CST originates in layer 5 of the sensorimotor cortex, descends through the inter-
nal capsule, cerebral peduncle, and ventral medulla, and projects to the spinal cord postnatally14,15. To selectively 
examine the trajectory of the CST axons, we performed DiI tracing. When DiI was injected into the motor cortex 
of live neonatal mice, CST axons were labeled up to the pyramidal decussation within 10 h (Fig. 1a,c–e).
In the DKO mice, most of the labeled fibers extended dorsally towards the superior colliculus and then 
returned to the brainstem, whereas some fibers invaded the superior and inferior colliculi (Fig. 1b,f). The fibers 
that returned to the medulla were defasciculated and positioned more laterally (Fig. 1b,h), which was in contrast 
to the tightly fasciculated bundle in the control mice (Fig. 1a,e). As a result, the width of the CST axon bundles 
in the medulla was significantly greater in the DKO mice than that in the control mice (202.6 μm in control 
and 374.4 μm in DKO, n = 4; P = 0.002635 by Welch’s t-test). Section analysis of the DiI-injected brains showed 
that the CST fibers of the DKO mice appeared to be almost normal until they reached the midbrain, where the 
misdirected fibers extended dorsolaterally along the brain surface (Supplementary Fig. S1p–t). In the medulla of 
the DKO mice, the pyramidal tract became thinner and broader (Supplementary Fig. S1u). These abnormalities 
were consistent with the defects detected by the previous neurofilament-M staining (Supplementary Fig. S1m–o). 
Additional defects were observed inside the DiI-injected brains: a small portion of the cortical fibers projected 
aberrantly towards the tectum through the thalamus (n = 4/4, Supplementary Fig. S1r) and some mice showed 
midline-crossing defects in the corpus callosum (n = 1/4, data not shown).
Because the striking abnormalities of the CST axons were present on the brain surface and could be detected 
by neurofilament antibody, we performed whole-mount neurofilament-M staining at embryonic day 18.5 (E18.5), 
when the CST axons reach the medulla. In the control brain, the CST axons were seen as a large ventral bundle 
(the cerebral peduncle): they emerged onto the brain surface from the posterolateral side of the hypothalamus and 
immediately turned medially towards the pons (Fig. 1a,i–j). In contrast, in the Sulf1/2 DKO mice, the CST axons 
extended dorsally and were defasciculated on the lateral surface of the midbrain (Fig. 1b,k). When viewed from 
the ventral aspect, the CST fibers turned laterally after exiting the hypothalamus (Fig. 1b,l). Thus, this method can 
assess the CST defects in DKO mice clearly.
Because whole-mount neurofilament staining is more useful to examine the overall changes in axonal tra-
jectories on the brain surface without experimental bias and because many samples can be evaluated without 
sectioning, we adopted this method in the subsequent experiments to determine the presence of CST abnormal-
ities. When a number of Sulf1/2 DKO mice were examined, the CST defects were somewhat variable between 
individuals. Most of the DKO mice showed an aberrant CST trajectory in the midbrain, as shown in Fig. 1k,l (62 
of 70 tracts examined, Supplementary Fig. S1y and S1y’). In one severe case, all the CST axons turned dorsally and 
projected to the superior colliculus (1/70, Supplementary Fig. S1z and S1z’). In less severe cases, the CST axons 
turned medially towards the pons after exiting the hypothalamus but were located lateral to the medial lemnis-
cus (7/70, Supplementary Fig. S1x and S1x’), whereas they overrode the medial lemniscus in the control brains 
(Supplementary Fig. S1w’). In summary, all the Sulf1/2 DKO mice showed CST axon guidance defects, whereas 
no CST abnormalities were observed in the Sulf1−/−, Sulf2−/−, Sulf1−/−;Sulf2+/−, or Sulf1+/−;Sulf2−/− mice (data 
not shown). We thus focused on this robust defect and explored the underlying mechanism.
Electroporation of Sulf Genes Into the Hypothalamus and Midbrain Rescues the CST Defects in 
Sulf1/2 DKO Mice. To examine the Sulf expression potentially relevant to CST development, we performed 
in situ hybridization. Because CST axons pass through the cerebral peduncle at E15 and reach the medulla at 
E17–18 in mice14,15, we examined Sulf expression at E15.5. Sulf1 mRNA showed relatively restricted expression 
in the choroid plexus, the cortical hem, and the ventricular zone of the third ventricle (Fig. 2a–f), whereas Sulf2 
mRNA showed broader expression in the brain (Fig. 2a’–f ’). In the cortical plate, Sulf1 and Sulf2 mRNAs were 
observed in the presumptive layer 6 and in layers 5–6, respectively (Fig. 2a and a’). Outside the cerebral cortex, 
Sulf1 and Sulf2 showed strong and overlapping expression in the ventricular zone of the third ventricle and aque-
duct (Fig. 2c–f and 2c’–f ’).
To determine which brain regions of Sulf expression are required for CST formation, we performed in vivo 
rescue of the Sulf1/2 DKO phenotype by local introduction of Sulf genes. For this purpose, we electroporated 
Sulf1 and Sulf2 with EGFP into various brain areas at E12.5 and examined the EGFP-positive area and CST tra-
jectory at E18.5. We performed electroporation at E12.5 because it was before the CST axons began to extend 
and because the ventricles of the embryonic brains were widely open, enabling easy introducion of exogenous 
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genes into various regions. To induce strong and ubiquitous expression, we used a pCX vector carrying the CAG 
promoter16. By holding embryos with electrodes at different angles, exogenous genes could be electroporated into 
restricted brain regions of interest (Fig. 2g–t). Because the coelectroporated genes were coexpressed in the same 
brain region (Fig. 2u–w and Supplementary Fig. S2a–d), the EGFP-positive areas represented the brain regions 
where Sulf genes had been introduced.
Figure 1. CST Axon Guidance Defects in Sulf1/2 DKO Mice. (a,b) Trajectory of the CST. Boxes show the 
areas of the pictures in (c–l). (c–h) Fluorescence images of P0 brains injected with DiI in the motor cortices. 
Lateral (c,f) and ventral (d,e,g,h) views of the control (Sulf1−/−;Sulf2+/−; c–e) and Sulf1/2 DKO brains (f–h) 
are shown. Sulf1/2 DKO mice showed abnormal defasciculated axons (closed arrowheads in f, box in b). 
The dashed lines indicate the midline. The average intensity of fluorescence signals in the midbrain area was 
significantly higher in the DKO mice than that in the control mice (18.388 arbitrary unit in control and 29.096 
in DKO; n = 4, P = 0.018637 by Welch’s t-test). (i–l) Whole-mount neurofilament staining of the E18.5 brain. 
Lateral views (i,k) and ventral views (j,l) of control (Sulf1−/−; i–j) and Sulf1/2 DKO brains (k,l) are shown. The 
cerebral cortices were removed. Abnormal fibers (closed arrowheads) were observed in the Sulf1/2 DKO brain 
(k,l). Open arrowheads in (i,j) indicate the normal cerebral peduncle. Statistical analyses of the neurofilament-
positive fibers in the midbrain (i,k) are shown in Supplementary Table 1. Cb, cerebellum; cp, cerebral peduncle; 
Cx, cerebral cortex; Hy, hypothalamus; IC, inferior colliculus; MO, medulla oblongata; ot, optic tract; Pn, 
pons; SC, superior colliculus. Anterior-posterior (A-P), dorsal-ventral (D-V), and medial-lateral (M-L) body 
axes are shown. Scale bars indicate 750 μm (c,f), 500 μm (d,e,g,h), 1.0 mm (i,k), and 600 μm (j,l), See also 
Supplementary Fig. S1.
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Figure 2. Expression of Sulf1 and Sulf2 mRNAs and In Vivo Rescue of the CST Defects in Sulf1/2 DKO 
Mice. (a–f,a’–f ’) In situ hybridization of Sulf1 (a–f) and Sulf2 (a’–f ’) in the coronal sections of E15.5 brains. 
Arrowheads show high and overlapping expression of Sulf1 and Sulf2 in the ventricular zone of the third 
ventricle and aqueduct. Positions of the sections in (a–f) and (a’–f ’) are shown in the upper margin. (g–t) 
Electroporation-mediated rescue of the CST defects in Sulf1/2 DKO mice. The indicated plasmids and pCX-
EGFP were electroporated into E12.5 Sulf1/2 DKO brains. At E18.5, EGFP expression and the CST trajectory 
were examined. Representative results showing electroporation into the medial cerebral cortex (g–j), from 
the superior colliculus to the cerebellum (k–n), and from the hypothalamus to the midbrain (Mb, o–t) are 
shown. Figures (q,r) and (s,t) show the electroporated and nonelectroporated sides of the same embryo, 
respectively. Dorsal (g,k,o), lateral (h,i,l,m,p,q,s), and ventral (j,n,r,t) views are shown. EGFP fluorescence 
in the hypothalamus in (h) shows transmission through the contralateral side. Arrows indicate the sites of 
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Electroporation of pCX-Sulf1/2 into the cerebral cortex (5 mice; Fig. 2g–j) and into the area from the superior 
colliculus to the cerebellum (3 mice; Fig. 2k–n) failed to rescue the DKO phenotype. In contrast, when Sulf1/2 
were electroporated into the area including the hypothalamus and midbrain, the CST defects were completely 
restored to normal only on the electroporated side (6 mice; Fig. 2o–t). Moreover, a mutant Sulf1 lacking enzyme 
activity could not rescue the phenotype (4 mice; Supplementary Fig. S2e–h), whereas wild-type Sulf1 or Sulf2 
could rescue the defects (4 mice for Sulf1 and 3 mice for Sulf2; Supplementary Fig. S2i–p). These data indicate that 
Sulf activities are required not in the cortical axons, but in the middle of the CST trajectory.
Sulf Expression in the Radial Glial Cells Along the Third Ventricle Is Required for Navigating 
CST Axons. Because the CST defects were observed only when all 4 Sulf alleles were lost, it is plausible that 
the brain areas expressing both Sulf1 and Sulf2 are associated with the defects. Given that electroporation of Sulf 
genes into the hypothalamus and the midbrain rescued the DKO phenotype, it is likely that strong overlapping 
expression of Sulf1/2 in the ventricular zone of the third ventricle plays a critical role. We thus wondered whether 
selective electroporation of Sulf genes into these cells could rescue the DKO phenotype. Conveniently, we found 
that the pEF-BOS vector17 can induce relatively specific expression in these cells, although the underlying mech-
anism is unknown. When electroporated into the hypothalamus and midbrain, pEF-BOS-EGFP induced weak 
but restricted expression in the cells in the ventricular zone (Fig. 3a,b,e), whereas pCX-EGFP induced wide-
spread expression (Fig. 2o,p and Supplementary Fig. S2a,c). We therefore electroporated pEF-BOS-Sulf1 and 
pEF-BOS-Sulf2 into the Sulf1/2 DKO brain and found that the CST defects were completely rescued (3 mice; 
Fig. 3c,d). These data indicate that Sulf expression in the ventricular zone of the third ventricle was sufficient to 
steer CST axons properly.
To examine Sulf protein localization in the brain, we performed immunostaining. Both Sulf1 and Sulf2 pro-
teins were detected in the cells in the ventricular zone along the third ventricle (Fig. 3f4,h4), consistent with 
the localization of Sulf1 and Sulf2 mRNA. Both signals were abolished by disruption of Sulf genes, indicating 
the specificity of the immunostaining (Fig. 3g4,i4). Interestingly, both proteins were additionally detected on the 
brain surface: strongly near the cerebral peduncle and weakly in the hypothalamus (Fig. 3f2–3,h2–3). Sulf pro-
teins induced by electroporation displayed similar distribution patterns (Supplementary Fig. S2b3,d3). Because 
EGFP-positive cells in the pEF-BOS-EGFP-electroporated brain were radial glial cells extending long processes 
from the ventricular zone to the pial surface (Fig. 3e’–3e”), we surmised that Sulf proteins produced by radial glial 
cells are delivered to the pial surface.
To test whether disruption of Sulf genes alters HS sulfation patterns locally where Sulf proteins are present, 
we performed immunostaining of HS using several anti-HS phage display antibodies at E15.5, even though our 
disaccharide analysis had already revealed that trisulfated HS disaccharides were increased in the whole brains of 
the neonatal DKO mice (Supplementary Fig. S1a,b). The signals with AO4B08 and RB4CD12 antibodies, which 
recognize HS disaccharides containing the 2-O-, 6-O-, and N-sulfate groups18,19, were stronger on the brain sur-
face of the DKO mice than on that of the control mice, whereas the signals in the blood vessels were comparable 
between the DKO and the control mice (Fig. 3j,k and Supplementary Fig. S2q–r). The increases in AO4B08 and 
RB4CD12 signals were particularly prominent in the cerebral peduncle and hypothalamus. Conversely, the sig-
nals with HS4E4, which recognizes HS disaccharides containing the 2-O- and N-sulfate groups18, were weaker 
in the DKO mice (Fig. 3l,m). These findings indicate that the proportion of trisulfated HS disaccharides was 
increased on the pial surface as a result of Sulf1/2 disruption. Because the changes were most robust around the 
CST trajectory, it is likely that this local change in HS contributes to the emergence of abnormalities in CST axons.
Slit Overexpression Mimics the Axon Guidance Defects in Sulf1/2 DKO Mice. What are the mech-
anisms underlying the CST defects in Sulf1/2 DKO mice? We hypothesized that increases in trisulfated HS altered 
the amount or localization of some axon guidance protein(s). To determine the responsible molecule(s), we first 
investigated all the known axon guidance proteins expressed in the hypothalamus and midbrain at E15.5 by an 
unbiased approach using proteomic analysis. Because Sulfs modified HS in the basement membrane, the menin-
ges (enriched in the basement membrane) were analyzed using liquid chromatography-ion trap mass spectrom-
etry (LC-MS/MS). The table in Supplementary Fig. S3a shows the list of axon guidance proteins detected by this 
method. Slit2, Sema3E, Sema4G, Sema5B, and Sema6B were detected only in the DKO brain, suggesting that 
they were more abundant in the DKO mice. In contrast, Sema4D and EphrinB2 were detected only in the control 
brain, suggesting that they were less abundant in the DKO mice. Slit1 showed the same spectral counts in the 
control and the DKO mice.
To pin down the candidate molecule(s), we examined their expression patterns and tested whether their over-
expression induced any changes in the CST trajectory. Electroporation of pCX-Sema3e into wild-type brains 
induced lateral shift of the CST in the cerebral peduncle (3 mice, Fig. 4i,j), resembling the weak DKO phenotype. 
electroporation. Closed arrowheads (i,j,m,n,s,t) indicate abnormal CST fibers in the Sulf1/2 DKO brain, 
whereas open arrowheads (q,r) indicate the CST restored by electroporation. Statistical analyses of the 
neurofilament-positive fibers in the midbrain (q,s) are shown in Supplementary Table 1. (u–w) Colocalization 
of coelectroporated genes. When EGFP and DsRed2 were electroporated together, they were expressed in the 
same brain regions. Aq, aqueduct; ChP, choroid plexus; CP, cortical plate; cst, corticospinal tract; FM, foramen 
of Monro; ml, medial lemniscus; OB, olfactory bulb; PoA, preoptic area; preTc, pretectum; Sp, septum; Th; 
thalamus; V3, third ventricle. Anterior-posterior (A-P), dorsal-ventral (D-V), and medial-lateral (M-L) body 
axes are shown. Scale bars indicate 300 μm (a,a’), 750 μm (b–f,b’–f ’), 3.1 mm (g,h,k,l,o,p), 550 μm (i,j,n,r,t), 1.0 
mm (m,q,s), and 2.1 mm (u–w). See also Supplementary Fig. S2.
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Sema3e mRNA was expressed near the cerebral peduncle (Fig. 4a–c), suggesting possible involvement in CST 
formation. However, Sema3e overexpression did not elicit such CST defects as observed in the Sulf1/2 DKO 
brain, indicating that excess Sema3E alone cannot account for the DKO phenotype. Electroporation of pCX-Slit2 
at E12.5 caused very strong repulsion of the CST axons (Fig. 4m), similar to the severe DKO phenotype and con-
sistent with previous observations20,21. Induction of weaker Slit2 expression by electroporation of pEF-BOS-Slit2 
(pEF-BOS induces weaker expression than pCX) at E13.0 (lower electroporation efficiency than at E12.5) led 
Figure 3. Electroporation of Sulf Genes Into the Radial Glial Cells in the Hypothalamus Restores the CST 
Defects in Sulf1/2 DKO Mice. (a–d) Electroporation-mediated rescue of the CST defects in Sulf1/2 DKO 
mice. The indicated plasmids and pEF-BOS-EGFP were electroporated into E12.5 Sulf1/2 DKO brains. At 
E18.5, EGFP expression and the CST trajectory were examined. Dorsal (a), lateral (b,c), and ventral (d) views 
are shown. Open arrowheads (c,d) indicate the CST restored by electroporation. Arrows indicate the sites of 
electroporation. Anterior-posterior (A-P), dorsal-ventral (D-V), and medial-lateral (M-L) body axes are shown. 
Statistical analyses of the neurofilament-positive fibers in the midbrain (c) are shown in Supplementary Table 1. 
(e–e”) EGFP expression in pEF-BOS-EGFP-electroporated brains. (e’) shows the immunohistochemistry with 
anti-EGFP antibody. (e”) shows the magnified picture in the boxed region in (e’). (f–m) Immunohistochemistry 
of the E15.5 brain with anti-Sulf or anti-HS antibodies. The signals with anti-Sulf1 in the Sulf2 KO brain (f) 
were abolished in the Sulf1/2 DKO brain (g), whereas the signals with anti-Sulf2 in the wild-type brain (h) were 
abolished in the Sulf2 KO (i) brain. Sulf2 KO and Sulf1/2 DKO brains were used for anti-Sulf1 staining because 
anti-Sulf1 antibody weakly crossreacts with Sulf2 protein. The signals with anti-HS AO4B08 (j,k) and anti-HS 
HS4E4 (l,m) in the control (Sulf1−/−) brain (j,l) were increased and decreased in the Sulf1/2 DKO brain (k,m), 
respectively. Pictures (f1–m1), (f2–m2), (f3–m3), and (f4–i4) show the boxed regions with the corresponding 
numbers in the brain section in the left margin. Asterisks show blood vessels. Scale bars indicate 2.0 mm (a,b), 
650 μm (c,e,e’), 350 μm (d), 210 μm (e”), and 150 μm (f–m). See also Supplementary Fig. S2.
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Figure 4. Slit2 and Sema3e Overexpression Causes the CST Defects. (a–f) In situ hybridization of Sema3e and 
Slit2 in coronal sections of the E15.5 brain. Sema3e was expressed near the cerebral peduncle (a–c, arrowheads), 
whereas Slit2 was highly expressed in the ventricular zone of the posterior hypothalamus and the dorsal 
midline of the aqueduct (d–f, arrowheads). Positions of the sections in (a–f) are shown in the upper margin. 
(g–p) Effects of Sema3e and Slit2 overexpression on CST axons. The indicated plasmids and pCX-EGFP were 
electroporated into wild-type brains at E12.5 (g–m) or E13.0 (n–p). At E18.5, EGFP expression and the CST 
trajectory were examined. Sema3e overexpression induced lateral shift of the CST (i,j, arrowheads), which was 
similar to the mild phenotype of Sulf1/2 DKO mice. Strong Slit2 overexpression by pCX-Slit2 electroporation 
strongly repelled CST axons (m, arrowheads), which was similar to the severe phenotype of Sulf1/2 DKO 
mice. Next, weaker Slit2 overexpression was induced by electroporation of pEF-BOS-Slit2 at E13.0, when 
electroporation efficiency decreased owing to the narrowing of the ventricles (compare the EGFP signals 
induced by pCX-EGFP electroporated at E12.5 [4g–h and 4k–l] and at E13.0 [4n–o]). Mild Slit2 expression thus 
obtained induced weaker CST defects (p, arrowheads), which was similar to the moderate phenotype of Sulf1/2 
DKO mice. Defects in retinotectal projection were also observed (p, arrows). Arrows in (g–h), (k–l), and (n–o) 
indicate the sites of electroporation. Anterior-posterior (A-P), dorsal-ventral (D-V), and medial-lateral (M-L) 
body axes are shown. Statistical analyses of the neurofilament-positive fibers in the midbrain (i,p) are shown in 
Supplementary Table 1. Scale bars indicate 550 μm (a–f), 1.8 mm (g,h,k,l,n,o), and 600 μm (i,j,m,p). See also 
Supplementary Fig. S3.
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to CST defects that were indistinguishable from those of the moderate DKO phenotype (Fig. 4p). Slit2 mRNA 
showed high expression in the ventricular zone of the third ventricle, especially in the posterior hypothalamus 
(Fig. 4d–f and Supplementary Fig. S3p–s), suggesting colocalization and possible collaboration with Sulf1/2. 
By contrast, Slit1 expression was not seen in the ventricular zone of the ventral third ventricle (Supplementary 
Fig. S3l–o), and therefore, Slit1 was thought to be irrelevant to the CST defects although its overexpression can 
induce repulsion of CST axons (Supplementary Fig. S3t–u). Electroporation of other candidate genes did not 
induce any CST abnormalities in the wild-type brains, nor did it rescue the DKO phenotype (Supplementary 
Fig. S3c,e,g,i,k).
Therefore, Slit2 turned out to be the best candidate that accounted for the CST defects observed in the Sulf1/2 
DKO mice. Given that Slit2 binds to HS with high affinity22 in a 6-O-sulfate-dependent manner23, increased 
trisulfated HS is expected to bind more Slit2 protein in Sulf1/2 DKO mice. Consistent with this prediction, the 
N-terminal fragment (an active form) of Slit2 protein was more abundant in the meninges of the DKO mice than 
in those of the control mice (Fig. 5i and Supplementary Fig. S4s). We thus hypothesized that increases in Slit2 
protein in the ventral brain region caused dorsal repulsion of the CST axons in the DKO mice.
Abnormally High Amounts of Slit2 Protein Accumulate on the Pial Surface of Sulf1/2 DKO Mice. 
To test this possibility, we wished to detect Slit2 protein in embryonic brains. However, because no antibodies 
for immunostaining Slit2 were available, we used the extracellular portion of Robo2, a Slit receptor, which was 
tagged with the Fc region of human IgG (Robo2-Fc; ref.24). First, we confirmed that Robo2-Fc bound to Slit2 
in the transfected cells (Supplementary Fig. S4a–d,f). Next, we tested Robo2-Fc binding on brain sections that 
were electroporated with pCX-FLAG-Slit2. When the brain sections were incubated with Robo2-Fc, the binding 
was clearly detected only on the electroporated side and was colocalized with the FLAG epitope (Supplementary 
Fig. S4m–r), indicating that Robo2-Fc can detect Slit2 protein in brain sections. Robo2-Fc binding was strongly 
detected on the brain surface in addition to the cell bodies of the electroporated cells in the ventricular zone and 
brain parenchyma.
We then tested whether the disruption of Sulf genes altered Slit localization. Robo2-Fc binding was hardly 
detectable in the control brains except for weak signals on the pial surface of the superior colliculus (Fig. 5a). In 
contrast, in Sulf1/2 DKO mice, strong Robo2-Fc binding was detected on the pial surface, especially in the areas 
of the cerebral peduncle and hypothalamus (Fig. 5b). Quantitative comparison revealed that the signal intensity 
in the Sulf1/2 DKO mice was significantly higher in the cerebral peduncle and hypothalamus than that in the 
controls but was comparable in the superior colliculus (Fig. 5f). Robo2-Fc binding was colocalized with laminin 
(Fig. 5g–h), suggesting that Slit protein was associated with the basement membrane. Furthermore, Robo2-Fc 
binding in the DKO brain was completely abolished by deletion of the Slit2 gene (namely in the triple KO brain), 
except for the weak signals in the superior colliculus (Fig. 5j–k and Supplementary Fig. S5a–e), suggesting that the 
Robo2-Fc binding signals in the cerebral peduncle and hypothalamus are indicative of Slit2 protein localization. 
These data clearly showed that Slit2 protein accumulated excessively in the ventral brain region of Sulf1/2 DKO 
mice.
The elevated levels of Robo2-Fc binding in Sulf1/2 DKO mice were restored to the control levels by electropo-
ration of Sulf1/2, which was performed under the same conditions as those used for the phenotype rescue exper-
iments, whereas electroporation of the mutant Sulf1 was ineffective (Fig. 5c–e). The morphology of the basement 
membrane and radial glial cells, as assessed by laminin and nestin immunostaining, was normal in the Sulf1/2 
DKO mice (Supplementary Fig. S5f–i). In addition, no increase in Slit2 mRNA expression was observed in the 
Sulf1/2 DKO mice (data not shown). Taken together, these data indicate that abnormally high amounts of Slit2 
protein accumulated in the ventral brain region, causing CST axon guidance defects in Sulf1/2 DKO mice (Fig. 6).
Abnormal Slit2 Protein Accumulation is Responsible for the CST Defects in Sulf1/2 DKO Mice. 
Finally, we tested whether reduction of Slit2 levels in Sulf1/2 DKO mice could restore the CST defects. First, we 
electroporated Slit2 siRNA into DKO brains but failed to reduce the Slit2 levels significantly and the DKO pheno-
type was not rescued (data not shown). Next, we produced Sulf1/2 DKO mice with heterozygous deletion of Slit2 
and found that the CST defects were not restored to normal. This was consistent with the finding that Robo2-Fc 
binding signals were still detected after deleting one allele of Slit2 (Supplementary Fig. S5b,e). Finally, we tried 
to reduce Slit activity by means of Robo2-Fc overexpression, which was shown to be effective in neutralizing 
Slit activity in vitro25,26. Strong overexpression of Robo2-Fc by pCX-Robo2-Fc electroporation restored the DKO 
phenotype on the electroporated side (n = 2/3 in Sulf1/2 DKO mice; n = 3/6 in Sulf1−/−;Sulf2−/−;Slit2+/− mice; 
Fig. 5l–m). However, even in the rescued mice, the restoration was not complete: the CST axons turned medially 
towards the pons but were located laterally to the medial lemniscus, resembling the weak phenotype of Sulf1/2 
DKO mice. The incidence of phenotype recovery in pCX-Robo2-Fc-electroporated embryos was significantly 
higher than the appearance frequency of the weak phenotype in nonelectroporated Sulf1/2 DKO mice (5/9 and 
7/70 for electroporated and nonelectroporated mice, respectively; P = 0.003, Fisher exact test). These data indi-
cate that suppression of Slit activity by Robo2-Fc overexpression led to the recovery of the CST defects in Sulf1/2 
DKO mice. The observation that Robo2-Fc did not completely rescue the CST defects might be explained by the 
weaker effects of other axon guidance molecules (for example, Sema3E). Taken together, our results demonstrate 
that abnormal accumulation of Slit2 protein is mainly responsible for the CST axon guidance defects in Sulf1/2 
DKO mice.
Discussion
In this study, we have demonstrated that Sulf-mediated trimming of 6-O-sulfate groups in HS is required for CST 
axon guidance. Normally, Sulfs produced by radial glial cells modify HS sulfation patterns in the pial basement 
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Figure 5. Slit2 Protein Accumulated Abnormally on the Pial Surface of the Posterior Hypothalamus of Sulf1/2 
DKO Mice. (a–e) Robo2-Fc binding on the brain sections of control (Sulf1−/−) and Sulf1/2 DKO mice and of 
Sulf1/2 DKO mice electroporated with the indicated plasmids. (a1–e1), (a2–e2), and (a3–e3) indicate the areas 
including the superior colliculus, cerebral peduncle, and hypothalamus, respectively (shown in the boxed 
areas in the left panel). Figures (a–c) and Figures (d,e) show opposite sides of the brain sections. Con, control 
side; Ep, electroporated side. (f) Quantitative analysis of Robo2-Fc binding. Average of the fluorescence 
intensity (arbitrary unit; a.u.) on the pial surface obtained by confocal microscopy in control mice (n = 3, 2 
Sulf1−/−;Sulf2+/− and 1 Sulf1−/−), Sulf1/2 DKO mice (n = 3), and Sulf1/2 DKO mice electroporated with pCX-
Sulf1/2 (n = 4) or pCX-Sulf1(C87A) (n = 4) are shown. Statistical significance was calculated using ANOVA with 
a Tukey-Kramer post hoc test (**P < 0.01; ***P < 0.001; ****P < 0.0001). (g,h) Colocalization of Robo2-Fc 
binding and anti-laminin immunostaining in the cerebral peduncle (g) and hypothalamus (h) of Sulf1/2 DKO 
mice. (i) Western blot analysis of Slit2 protein in the meninges isolated from the hypothalamus and midbrain of 
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membrane. Loss of Sulfs results in increases in 6-O-sulfated HS, leading to accumulation of Slit2 protein and dor-
sal displacement of the CST. This contrasts sharply with the phenotype of Slit/Robo KO mice, in which CST axons 
invade the ventral brain owing to the lack of repulsion21,27 (Fig. 6). We propose a novel regulatory mechanism by 
which HS desulfation secures accurate axon guidance by tempering Slit2 protein accumulation. Although we have 
presented unequivocal evidence that Slit2 is a major cause for this particular CST phenotype, possible involve-
ment of other molecules in other axon guidance defects is worthy of investigation in future.
Genetic studies in mice and zebrafish demonstrated requirement of HS biosynthesis in axon guidance2,4,28–30. 
More specifically, HS modification by specific sulfotransferases has also been implicated in axon guidance2,4,31–36. 
These studies indicate that presence of HS and its sulfate groups is essential for mediating axon guidance signals. 
Given that sulfate groups at specific positions in HS are required for the interaction between HS and signaling 
molecules23, desulfation is thought to be of the same importance as sulfation in the regulation of HS functions. 
Correspondingly, our present study has demonstrated that shaping of HS by removing sulfate groups at specific 
positions is important in axon guidance. Sulfs thus can act as a dynamic regulator that controls HS-dependent 
signaling in a spatiotemporal manner.
Although many lines of evidence indicate HS dependence of Slit/Robo signaling, how HS interacts with Slit/
Robo and regulates their signaling in vivo remains largely elusive, particularly in the vertebrate brain. We devised 
a method to detect Slit2 protein on brain sections and clearly demonstrated the localization of Slit2 protein on the 
pial basement membrane in the Sulf1/2 DKO brain. Moreover, we showed that Slit2 accumulation was associated 
with trisulfated HS disaccharides. Given that Slit2 binds strongly to 6-O-sulfated heparin23, it is likely that Slit2 
accumulation in the DKO brain was due to increased stability of Slit2 by 6-O-sulfated HS. Interestingly, Robo2-Fc 
binding in the control brain was below the detection level in the examined area, suggesting rapid diffusion and/
or degradation of Slit2 protein in vivo. This means that dissociation of Slit2 from HS by means of desulfation 
contributes to fine-tuning of Slit2 activity. In this context, it is noteworthy that in our proteomic analysis of the 
control brain, a Slit2 fragment was detected in a small-sized fraction (53–65 kDa), but not in the large-sized frac-
tion corresponding to an active N-terminal Slit2 fragment (100–140 kDa).
Precise patterning of Slit localization is indispensable for accurate guidance of growing axons. In addition 
to HS, glycosylated dystroglycan and type IV collagen were implicated in the interaction with Slit protein and 
Slit-mediated axon guidance37,38. In particular, in zebrafish, Slit1 protein was shown to be translocated to the sur-
face of the tectum by the actions of the radial glial cells and anchored to the basement membrane via interaction 
with type IV collagen37. Combined with these data, our findings suggest that transport of Slit protein to the brain 
surface by radial glial cells is a generalized mechanism controlling axon guidance. Two recent papers reported 
a similar mechanism in which netrin-1 protein produced by ventricular zone progenitor cells is transported to 
the pial surface to guide commissural axons in the spinal cord and hindbrain39,40, although the involvement of 
HS remains to be examined. Future studies are required to clarify how Sulfs play cooperative roles in anchoring 
guidance proteins in the basement membrane with dystroglycan and type IV collagen.
Our results also have an important implication in that Slit2 activity can be regulated by changing the HS 
microstructure in the extracellular environment without altering Slit2 expression. Manipulation of the localiza-
tion and activity of axon guidance molecules by Sulfs or heparin-related chemicals41 may be useful to control the 
action of chemorepellents for promoting regeneration of CST axons.
Methods
Knockout Mice. Sulf knockout mice were generated as described previously19. Offspring of mice backcrossed 
to C57BL/6N for 5 generations (N5 generation) were used. Slit2 knockout mice were obtained from Mutant 
Mouse Regional Resource Centers. Noon of the day on which a vaginal plug was observed was taken as embry-
onic day 0.5 (E0.5). All animal experiments were approved by and performed according to the guidelines of the 
Animal Care and Use Committee of the University of Tsukuba.
Disaccharide Analysis of Heparan Sulfate and Chondroitin Sulfate. Disaccharide analysis was per-
formed as described previously19 by using neonatal brains because most of the DKO mice died within a day of 
birth. In brief, acetone-extracted neonatal mouse brains were treated with 0.8 mg/ml protease (P5147; Sigma) at 
55 °C overnight, and then with 125 U benzonase (Sigma) at 37 °C for 2 h. After centrifugation, supernatants were 
purified with Vivapure D Mini M (Vivascience) and concentrated with Ultrafree-MC Biomax-5 (Millipore). The 
purified glycosaminoglycans were treated at 37 °C overnight with a mixture of 1 mIU of heparinase I (Sigma), 
1 mIU of heparitinase I (Seikagaku), and 1 mIU of heparitinase II (Seikagaku) or with a mixture of 50 mIU 
of chondroitinase ABC (Seikagaku) and 50 mIU of chondroitinase ACII (Seikagaku). Unsaturated disaccha-
rides were analyzed by ion-pair reversed-phase chromatography. An NaCl gradient (2–106 mM) in 1.2 mM 
E15.5 mice. Slit2 was more abundant in Sulf1/2 DKO mice than in the control (Sulf2−/−) mice. FL and N indicate 
the full-length (~180 kDa) and N-terminal fragments (~130 kDa), respectively. Addition of blocking peptide 
abolished the bands (right panel), indicating the specificity of the antibody. Full-length blots that were used for 
this picture are shown in Supplementary Fig. S7. (j,k) Robo2-Fc binding was completely abolished in the Sulf1/
Sulf2/Slit2 triple knockout (TKO) brain. (l,m) Neutralization of Slit rescues the CST defects in Sulf1/2 DKO 
mice. The plasmids pCX-Robo2-Fc and pCX-EGFP were electroporated into E12.5 Sulf1/2 DKO brains, and the 
CST trajectory was examined at E18.5. The CST was nearly normalized by electroporation (open arrowheads) 
but lay slightly lateral to the medial lemniscus (ml). Anterior-posterior (A-P), dorsal-ventral (D-V), and medial-
lateral (M-L) body axes are shown. Scale bars indicate 100 μm (a–e,j,k), 50 μm (g,h), and 500 μm (l,m). See also 
Supplementary Fig. S4–7.
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tetra-n-butylammonium hydrogen sulfate (Wako Pure Chemical Industries) and 8.5% acetonitrile (Sigma) was 
applied on a Senshu Pak Docosil column (4.6 × 150 mm, particle size 5 μm; Senshu Scientific) at 55 °C using 
an HPLC system, the Alliance 2695 separations module (Waters Corporation). Postcolumn derivatization with 
2-cyanoacetamide (Wako Pure Chemical Industries) was performed at 125 °C using a Post Column Reaction 
Module (Waters Corporation) and Temperature Control Module II (Waters Corporation). The effluent was 
monitored fluorometrically using a 2475 Multi-channel Fluorescence Detector (excitation 346 nm, emission 
410 nm; Waters Corporation). Peaks were identified and quantified by comparison with authentic unsaturated 
disaccharide markers, an Unsaturated HS/HEP-Disaccharide Kit (H Mix; Seikagaku), ΔUA2S-GlcNAc, and 
ΔUA2S-GlcNAc6S (Dextra Laboratories), and an Unsaturated Chondro-Disaccharide Kit (C-Kit) (Seikagaku). 
The chromatogram was analyzed using Empower software (Waters Corporation), and the results were statistically 
analyzed using two-way ANOVA with a Bonferroni post hoc test.
Histology and Immunohistochemistry. Cryostat (10-μm thick) sections of paraformaldehyde 
(PFA)-fixed brains were used for immunohistochemistry. To detect Sulf or Slit proteins and HS, fresh-frozen 
sections fixed with 95% ethanol and 1% acetic acid were used42. The primary antibodies used were 
anti-neurofilament-M (1:1000; Zymed), anti-FLAG (1:500; Abcam, ab6711), anti-GFP (1:1000; Molecular 
Probes), anti-Sulf1 (1:50; Abcam, ab32763), anti-Sulf2 (1:50; Santa Cruz, M79), anti-HS (1:5; AO4B08; refs18,19), 
anti-nestin (1:1000; Chemicon), and anti-laminin (1:1000; Sigma). The secondary antibodies used were 
peroxidase-conjugated anti-mouse IgG (1:200; Chemicon) and Alexa488- or Alexa568-conjugated anti-rabbit 
IgG (1:250; Molecular Probes). A chromogenic reaction was carried out using a VECTASTAIN Elite ABC kit 
and a DAB substrate kit (Vector Laboratories). For immunofluorescence, cell nuclei were stained with 3.3 μM 
TO-PRO-3 iodide (Molecular Probes). Whole-mount immunostaining was done (with minor modifications) 
using the same reagents after the meninges were removed43.
DiI Tracing of the Corticospinal Tract. DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine per-
chlorate; Molecular Probes), dissolved in dimethylformamide, was injected into the motor cortices of neonatal 
mice by the use of glass micropipettes. The mice were perfusion-fixed with 4% PFA/PBS approximately 10 h after 
the injection. The dissected brains and vibratome sections (100-μm thick) were observed and photographed using 
a fluorescence stereoscopic microscope (MZ FL III; Leica) and a fluorescence microscope (Axioplan2; Zeiss), 
respectively.
In Situ Hybridization. In situ hybridization was performed as described previously44. In brief, 10-μm-thick 
cryostat sections were hybridized with a 1 μg/ml digoxigenin (DIG)-labeled antisense RNA probe at 65 °C for 
16 h. After washing, the slides were incubated with an alkaline phosphatase-conjugated anti-DIG antibody 
(Roche) at 4 °C for 16 h. Signals were detected using BM purple (Roche Diagnostics) in the presence of 2 mM 
levamisole (Sigma) at room temperature for 3 to 5 d.
Figure 6. Summary of the CST Phenotypes. In control mice, Sulf1/2 and Slit2 proteins, produced by the 
radial glial cells, are present on the pial surface. In Sulf1/2 DKO mice, increased 6-O-sulfated HS results in 
excessive accumulation of Slit2 protein (shown in dark blue) in the posterior hypothalamus, leading to dorsal 
displacement of the CST. Because DKO mice die within a day of birth, the CST caudal to the pyramidal 
decussation was not examined (dashed lines). In Slit2 KO mice, the CST axons invade the ventral forebrain 
owing to the lack of repulsion by Slit2.
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In Utero Electroporation. In utero electroporation was performed as previously described44. The cDNAs 
were subcloned into a pCX or pEF-BOS vector16,17. A DNA solution (2.0–2.5 μl) containing a total of 600 nM of 
the expression constructs was injected into the lateral ventricle of E12.5 or E13.0 mouse embryos. Five square 
electric pulses (35 V, 50 ms duration, 1 pulse/s) were delivered using an electroporator (CUY21; Nepa Gene) and 
a 3-mm electrode (CUY650P3; Nepa Gene).
Plasmid Constructs for Electroporation. The plasmids used in this study were obtained as fol-
lows. EGFP was derived from pEGFP-N3 (Clontech). Rat Sulf1 (SulfFP1) and Sulf2 (SulfFP2) were previously 
described19,45. The point mutation in Sulf1(C87A) was introduced by PCR. Mouse cDNAs Slit1 (BC062091), 
Sema3e (IMAGE:5357516), Sema4d (IMAGE:6509473), Sema4g (IMAGE:6395010), Sema5b (IMAGE:5719939), 
and Efnb2 (IMAGE:6827408) were obtained from the IMAGE consortium clone collection. Mouse Slit2 
(G730002D07) and Sema6b (G730036J03) were obtained from RIKEN Mouse FANTOM Clones (DNAFORM). 
Because both the Slit1 and the Slit2 clones contained short deletions, the incorrect sequences were replaced with 
the correct sequences that were amplified by RT-PCR, followed by sequence confirmation. Rat Robo1 and Robo2 
cDNAs were amplified by RT-PCR, and their whole sequences determined to confirm that they contained the 
correct sequences.
Sulf1 was tagged with either a FLAG peptide (DYKDDDDK) or a Myc peptide (EQKLISEEDL) plus the 
6xHis tag at its C-terminus. Sulf2 was tagged with the Myc peptide at its C-terminus. Sulf cDNAs were subcloned 
into the pCX vector16 and pEF-BOS vector17. For the rescue experiments, pCX-Sulf1-FLAG, pCX-Sulf2-Myc, 
pEF-BOS-Sulf1-FLAG, and pEF-BOS-Sulf2-Myc were used; for the sake of simplicity, they are denoted in the 
text as pCX-Sulf1, pCX-Sulf2, pEF-BOS-Sulf1, and pEF-BOS-Sulf2, respectively. In the experiments in which 
Sulf protein localization was examined, Sulf1-Myc-His and Sulf2-Myc were subcloned into a pCX vector con-
taining a Kozak sequence (GCCACCATG; the underline is the initiation codon), a signal sequence from the 
human CD8A gene (ALPVTALLLPLALLLHAARP), the FLAG peptide, and the 6xHis tag. Sulf1 and Sulf2 are 
connected to the above sequence from the positions of the 20th and 25th amino acids, respectively (both are 
the N-termini of the mature protein predicted by the SignalP 3.0 algorithm [http://www.cbs.dtu.dk/services/
SignalP/]). For simplicity, the expression constructs created, pCX-Kozak-SS-FLAG-His-Sulf1-Myc-His and 
pCX-Kozak-SS-FLAG-His-Sulf2-Myc, are denoted in the text as pCX-FLAG-Sulf1 and pCX-FLAG-Sulf2, 
respectively.
The mouse cDNAs Slit1, Slit2, Sema3e, Sema4d, Sema4g, Sema5b, Sema6b, and Efnb2 were subcloned into 
a pCX vector (and a pEF-BOS vector for Slits) that contained the Kozak sequence, the signal sequence from 
the human CD8A gene, the FLAG peptide, and the 6xHis tag. Slit1, Slit2, Sema3E, Sema4D, Sema4G, Sema5B, 
Sema6B, and EphrinB2 were connected to the above sequence from the positions of the 33rd, 26th, 26th, 24th, 18th, 
27th, 17th, and 30th amino acids, respectively (all are the N-termini of the mature protein predicted by the SignalP 
3.0 algorithm). For simplicity, they are denoted in the text as pCX-Slit1, pCX-Slit2, pCX-Sema3e, pCX-Sema4d, 
pCX-Sema4g, pCX-Sema5b, pCX-Sema6b, and pCX-Efnb2, respectively. In the in vitro Robo2-Fc binding exper-
iments, rat Slit2 tagged with an HA sequence (YPYDVPDYA) was subcloned into a pCEP4 vector (Invitrogen) 
containing the Kozak sequence, the signal sequence from the human CD8A gene, the FLAG peptide, and the 
6xHis tag.
LC-MS/MS Analysis. Liquid choromatography-ion trap mass spectrometry (LC-MS/MS) analysis was per-
formed as described previously46. Briefly, the samples were separated by SDS-PAGE and the gel was cut into 15 
pieces. The gel pieces were repeatedly soaked in 25 mM triethylammonium bicarbonate (TEAB), pH 8.0, contain-
ing 50% acetonitrile for 30 min. After being dried in a Savant Speed-Vac concentrator (Thermo Fisher Scientific), 
the gel was incubated in 25 mM TEAB, pH 8.0, containing 75–150 ng of modified trypsin (Roche Diagnostics) 
at 37 °C for 16–20 h. The digest were extracted twice with 100–300 μl of 0.1% trifluoroacetic acid containing 60% 
acetonitrile. These 2 extracts were combined, dried in a Speed-Vac concentrator, and kept at −80 °C until the 
assay. The sample was resuspended in 0.1% formic acid containing 2% acetonitrile and applied to a DiNa HPLC 
system (KYA Technologies Corporation). A reverse-phase capillary column (Develosil ODS-HG5, 0.075 mm 
i.d. × 150 mm; Nomura Chemical) was used at a flow rate of 200 or 300 nl/min with a 4–80% linear gradient of 
acetonitrile. Eluted peptides were directly detected with an ion trap mass spectrometer (LXQ; Thermo Fisher 
Scientific) at a spray voltage of 1.9 kV and collision energy of 35%. The mass acquisition method consisted of 1 full 
MS survey scan followed by MS/MS scans of the most abundant precursor ions from the survey scan. Dynamic 
exclusion for the MS/MS spectra was set to 30 s. The data were analyzed with BioWorks (Thermo Fisher Scientific) 
and Mascot (Matrix Science) software.
Robo2-Fc Binding Assay. Cos-7 cells were transfected with pMT21-Robo2-Fc using LipofectAMINE 
Plus reagent (Life Technologies) or FuGene HD (Promega). After the cells were cultured in serum-free 
Opti-MEM I (Life Technologies) for 3 days, the conditioned medium was concentrated about 5-fold using an 
Amicon Ultra-15 filter (50k MCO; Millipore). For in vitro assays, 293EBNA cells (Life Technologies) transfected 
with pCEP4-FLAG-Slit1 or pCEP4-FLAG-Slit2 were incubated with Robo2-Fc in a PH buffer (PBS with 1% 
heat-inactivated normal goat serum) at room temperature for 1 h. After being washed, the cells were fixed with 
2% PFA/PBS, permeabilized in PHT (PH with 0.1% Triton-X100), and incubated with Cy3-labeled anti-human 
IgG antibody at room temperature for 30 min (1:350; Jackson ImmunoResearch).
For in situ detection, 10-μm-thick fresh-frozen sections of E15.5 mouse heads were fixed in 1% acetic acid 
and 95% ethanol at −20 °C overnight. After being washed with PBS and blocked with PHT at room tempera-
ture for 1 h, the slides were incubated with Robo2-Fc (about 2.5-fold concentrated) at 4 °C overnight. The slides 
were then washed with PHT and incubated with biotin-SP-conjugated anti-human IgG antibody (1:50; Jackson 
ImmunoResearch) at room temperature for 45 min and then with Alexa546-conjugated streptavidin (1:50; Life 
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Technologies) at room temperature for 15 min. In this preparation, the fluorescence signal of elecroporated EGFP 
was eliminated, and thereby the immunostaining was not disturbed.
A series of z-stack fluorescence images (1024 × 1024 pixels) was obtained using a laser-scanning microscope, 
the LSM510 with a 10x objective lens (Carl Zeiss). For quantitative comparison of the fluorescence intensity of 
the samples, the same parameters (pinhole, 80.3 μm; optimal interval, 6.54 μm; detector gain, 1000; amplifier 
offset, −0.1; amplifier gain, 1; scan speed, 9; average number, 2) were used for all scans. Three sections were used 
for each experimental condition. In each section, the single optical slice with the strongest intensity was selected 
for measurement. An outline of the brain surface was traced, and the fluorescence intensity in the traced area was 
measured.
Western Blot Analysis. Meninges or brains dissected from the hypothalamic and midbrain regions of E15.5 
mouse embryos were homogenized in a sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 5% sucrose, 0.01% 
bromophenol blue, 10% 2-mercaptoethanol). The primary antibodies used were anti-Slit2 (1:200, G-19; Santa 
Cruz Biotechnology), anti-actin (1:1000; Sigma), and anti-laminin (1:1000; Sigma). The secondary antibodies 
used were peroxidase-conjugated anti-goat or anti-rabbit IgG (1:2500; Jackson ImmunoResearch). Signals were 
detected using the ECL Plus Western Blotting Detection System (GE). The data of a control experiment that con-
firmed the specificy of anti-Slit2 antibody (G-19) are shown in Supplemtary Fig. S6.
Statistics. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to 
those generally employed in the field. Statistical analyses for the data of Robo2-Fc binding and disaccharide anal-
ysis were done with ANOVA with Tukey-Kramer and Bonferroni post hoc tests, respectively. The Fisher exact test 
was used to analyze the incidence of phenotype recovery in pCX-Robo2-Fc-electroporated embryos. Welch’s t-test 
and a paired t-test were used to analyze the average fluorescence signal intensity, the width of the axon bundles, 
and the area of the neurofilament positive area (details of the analysis are described in Supplementary Table 1).
Data availability. The data that support the findings of this study are availiable from the corresponding 
author upon reasonable request.
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